Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back
Favorite
Like
Tweet
Print
Shumyla Saeed-Khawaja, MD
Director
Johnson & Johnson Innovative Medicine
Poster(s):
052: Nipocalimab Pharmacokinetic/Pharmacodynamic & Exposure-Response Modeling in Pregnancies at Risk for Early-onset Severe (EOS) HDFN
Sunday, September 8, 2024
5:00 PM – 7:00 PM
ET
166: Fetal & Neonatal Drug Exposure Following Nipocalimab Treatment in Pregnant Women at Risk of EOS-HDFN
Monday, September 9, 2024
5:00 PM – 7:00 PM
ET
